Defunct Company
Total Trials
16
As Lead Sponsor
15
As Collaborator
1
Total Enrollment
1,507
NCT03396393
Exploratory Study of DHA in Systemic Lupus Erythematosus Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2018
Completion: Dec 31, 2022
NCT04751539
A Dose-escalation Study of AND017 in Healthy Subjects
Phase: Phase 1
Start: Jul 16, 2018
Completion: Feb 11, 2019
NCT04712500
A Food-Effect Study of AND017 in Healthy Participants
Start: Jul 30, 2020
Completion: Aug 21, 2020
NCT04629287
Safety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection
Start: Nov 30, 2020
Completion: Feb 28, 2022
NCT04673799
Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.
Start: Feb 22, 2021
Completion: Oct 18, 2021
NCT04906473
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
Start: Jul 31, 2021
Completion: Oct 31, 2023
NCT05038449
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
Phase: N/A
Role: Collaborator
Start: Sep 6, 2021
Completion: Sep 1, 2023
NCT05035641
A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
Start: Oct 18, 2021
Completion: Jul 24, 2023
NCT05187832
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Start: Oct 5, 2022
Completion: May 31, 2026
NCT05745311
Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
Start: Mar 1, 2023
Completion: Jul 30, 2024
NCT05265325
A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
Start: May 3, 2023
Completion: Apr 25, 2024
NCT06302491
A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
Start: May 27, 2024
Completion: Jul 31, 2026
NCT06075030
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
Start: Dec 31, 2024
NCT06075043
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
Completion: Aug 31, 2027
NCT06304103
A Study of Efficacy and Safety of AND017 in Patients with Myelodysplastic Syndrome
Completion: May 31, 2027
NCT06867406
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
Start: Mar 7, 2025
Completion: Jan 31, 2026